Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2025)
Historic Operating Leases for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Q3 2025 value amounting to $5.0 million.
- Cumberland Pharmaceuticals' Operating Leases fell 726.84% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 726.84%. This contributed to the annual value of $5.3 million for FY2024, which is 616.71% down from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported Operating Leases of $5.0 million as of Q3 2025, which was down 726.84% from $5.1 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Operating Leases registered a high of $5.8 million during Q2 2023, and its lowest value of $229605.0 during Q3 2022.
- Its 5-year average for Operating Leases is $3.7 million, with a median of $5.0 million in 2025.
- Per our database at Business Quant, Cumberland Pharmaceuticals' Operating Leases crashed by 8265.55% in 2022 and then soared by 239262.34% in 2023.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Operating Leases stood at $1.1 million in 2021, then soared by 349.11% to $4.8 million in 2022, then grew by 18.6% to $5.6 million in 2023, then decreased by 6.17% to $5.3 million in 2024, then fell by 5.65% to $5.0 million in 2025.
- Its Operating Leases was $5.0 million in Q3 2025, compared to $5.1 million in Q2 2025 and $5.2 million in Q1 2025.